Therefore, intrinsic cardiac load and capacity do not improve in patients with heart failure with reduced ejection fraction, and patients HFpEF benefit only from the treatment of abnormal metabolism and inflammation.475,480,481 The encouraging results obtained with semaglutide in patients with heart failure and a preserved ejection fraction may provide a new option for this patient population, in which additional therapy, as well as another upstream therapy for patients with a higher BMI who have indications for this condition, is urgently needed
If a peptide medication freezes, the protein structure is permanently destroyed
When melanin is overproduced or unevenly distributed, visible darkened areas can develop, presenting as hyperpigmentation or patchy tone
GLP-1 medications originally got their start as blood sugar regulators for people with diabetes, but it turns out they have a big bonus and are great for weight loss too
Translation to human tissue outcomes is not demonstrated